Self-administration of gender-affirming hormones and supratherapeutic dosing are relatively common in Japanese transgender women.

Self-initiated hormonal treatments seem to affect the serum concentrations of gonadotropin and sex steroids and the complete blood count. The prevalence of transgender women with self-adjusted use of gender-affirming hormones is high, and an excess dose of hormones occasionally occurs.